Sector Chart GlaxoSmithKline Pharmaceuticals Limited NSE India S.E.
Stocks
GLAXO
INE159A01016
Pharmaceuticals
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,610.50 INR | +1.20% |
|
-1.35% | +5.90% |
| Aug. 03 | GSK India first-quarter profit rises on steady vaccine demand | RE |
| Aug. 03 | GlaxoSmithKline Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 1,062B | |||||
| 619B | |||||
| 431B | |||||
| 358B | |||||
| 293B |
Select your edition
All financial news and data tailored to specific country editions
